rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-5-3
|
pubmed:abstractText |
Postmenopausal osteoporotic women with pre-existing or new incident vertebral fractures are at high risk for future fracture, so prompt treatment is warranted. Risedronate has been shown to reduce the incidence of radiographically-defined vertebral fractures by approximately two-thirds within 1 year.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0300-7995
|
pubmed:author |
pubmed-author:AdachiJonathanJ,
pubmed-author:Di MunnoOmbrettaO,
pubmed-author:EastellRichardR,
pubmed-author:FelsenbergDieterD,
pubmed-author:HorlaitStephaneS,
pubmed-author:JacksonRebecca DRD,
pubmed-author:RizzoliRenéR,
pubmed-author:RouxChristianC,
pubmed-author:SeemanEgoE,
pubmed-author:SongcharoenSuthinS,
pubmed-author:ValentDavidD,
pubmed-author:WattsNelson BNB
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
433-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
|
pubmed:year |
2004
|
pubmed:articleTitle |
Efficacy of risedronate on clinical vertebral fractures within six months.
|
pubmed:affiliation |
Cochin Hospital, René Descartes University, Paris, France. christian.roux@cch.ap-hop-paris.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|